Literature DB >> 19652383

The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans.

Aixia Cheng1, Lingmei Sun, Xiuzhen Wu, Hongxiang Lou.   

Abstract

Biofilm formation plays a key role in the life cycles and subsistence of many microorganisms. The human fungal pathogen Candida albicans has a high propensity to develop biofilms and resulted resistant to traditional antifungal agents. Biofilms are composed of a mixture of cell types, including yeast, pseudohyphal and hyphal cells, and hyphae are a prominent feature of biofilms. Riccardin D is a macrocyclic bisbibenzyl isolated from the liverwort Dumortiera hirsute in our laboratory. In the present investigation, the XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] reduction assay and live/dead cell staining were employed for evaluating the effects of riccardin D on C. albicans biofilms. The results demonstrated that riccardin D can interfere with the biofilm formation. To investigate whether this effect was due to the inhibition of hyphae formation, morphological observation and real-time reverse transcriptase polymerase chain reaction (RT-PCR) were employed for evaluating the effects of riccardin D on the hyphae formation and the expression of hyphae specific genes. The results showed that the hyphae formation was strongly inhibited and the mRNA expression levels of hyphae specific genes were downregulated after riccardin D treatment. We concluded that riccardin D interfered with the biofilm formation of C. albicans through downregulating the expression of hyphae specific genes and inhibiting the formation of hyphae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652383     DOI: 10.1248/bpb.32.1417

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.

Authors:  Xia Xue; Xian-Jun Qu; Zu-Hua Gao; Cui-Cui Sun; Hui-Ping Liu; Cui-Rong Zhao; Yan-Na Cheng; Hong-Xiang Lou
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

Review 2.  Modulation of morphogenesis in Candida albicans by various small molecules.

Authors:  Julie Shareck; Pierre Belhumeur
Journal:  Eukaryot Cell       Date:  2011-06-03

3.  In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D.

Authors:  Yan Li; Yukui Ma; Li Zhang; Feng Guo; Lei Ren; Rui Yang; Ying Li; Hongxiang Lou
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

4.  Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.

Authors:  Li Zhang; Wenqiang Chang; Bin Sun; Matthias Groh; Andreas Speicher; Hongxiang Lou
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

5.  Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.

Authors:  Hui-Ping Liu; Zu-Hua Gao; Shu-Xiang Cui; De-Fu Sun; Yan Wang; Cui-Rong Zhao; Hong-Xiang Lou; Xian-Jun Qu
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

Review 6.  Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp.

Authors:  Tomasz M Karpiński; Marcin Ożarowski; Agnieszka Seremak-Mrozikiewicz; Hubert Wolski; Artur Adamczak
Journal:  J Fungi (Basel)       Date:  2021-05-05

7.  Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells.

Authors:  H Jiang; J Sun; Q Xu; Y Liu; J Wei; C Y F Young; H Yuan; H Lou
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

Review 8.  Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity.

Authors:  Samapika Nandy; Abhijit Dey
Journal:  Daru       Date:  2020-08-15       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.